ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,931 | -20.8% | 15,188 | -30.8% | 0.00% | – |
| Q2 2023 | $59,254 | -59.5% | 21,946 | -55.5% | 0.00% | – |
| Q1 2023 | $146,308 | -36.3% | 49,262 | -46.0% | 0.00% | -100.0% |
| Q4 2022 | $229,832 | -63.7% | 91,203 | -73.8% | 0.00% | -50.0% |
| Q3 2022 | $633,000 | +290.7% | 347,758 | +575.8% | 0.00% | +100.0% |
| Q2 2022 | $162,000 | -77.9% | 51,456 | -56.6% | 0.00% | -50.0% |
| Q1 2022 | $732,000 | +189.3% | 118,440 | +565.4% | 0.00% | +100.0% |
| Q4 2021 | $253,000 | -93.7% | 17,800 | -96.5% | 0.00% | -88.9% |
| Q3 2021 | $4,019,000 | +392.5% | 502,406 | +1658.9% | 0.01% | +350.0% |
| Q2 2021 | $816,000 | +82.6% | 28,564 | +85.7% | 0.00% | +100.0% |
| Q1 2021 | $447,000 | – | 15,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |